Trial Profile
Clinical Trials Insight: 700051831
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2009
Price :
$35
*
At a glance
- Drugs CCX 025 (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- Sponsors ChemoCentryx
- 16 Oct 2008 New trial record.